Dublin, April 23, 2019 (GLOBE NEWSWIRE) -- The "Alopecia Market Size, Share & Trends Analysis Report By Disease Type (Alopecia Areata, Androgenetic Alopecia), By End Use, By Sales Channel, By Gender, By Region, And Segment Forecasts, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global alopecia market size is anticipated to reach USD 12.37 billion by 2025. It is expected to expand at a CAGR of 5.5% during the forecast period. Technological advancements, growing disease prevalence, and environmental pollution, and increase in per-capita healthcare expenditures across the globe are anticipated to propel the growth.

Factors such as new product launches and technological advancements are also impacting the market dynamics. For instance, Hairmax Laser comb, Follinex Massager Comb, Lifemax Infrared Hair Brush, and hair growth renewing lasers are some of the products built on advanced technology. Also, the launch of new drugs is improving the treatment success rate and clinical outcomes.

Based on condition, the market is classified into alopecia areata, androgenetic alopecia, and others. Androgenetic alopecia segment led the market in 2018 with revenue of USD 7,242.7 million and is anticipated to grow at a lucrative CAGR over the forecast period. Factors responsible for high revenue of this segment include availability of various treatments such as topical treatments and oral treatments involving the use of minoxidil and finasteride and surgical treatments like hair transplantation and replacement. On the other hand, alopecia areata is anticipated to expand at the fastest CAGR of 6.3% over the forecast period.

On the basis of end use, the alopecia market is segmented into homecare settings and dermatology clinics. Dermatology clinics led the market in 2018 with a revenue of USD 4,696.4 million, due to the presence of a large number of dermatology clinics with new technologies and high adoption of prescription hair care products. Homecare settings segment is anticipated to register the fastest CAGR of 6% during the forecast period. Increasing availability of many new OTC medications and products along with increasing preference for convenience and ease of use are some of the factors responsible for this growth.

North America led the market in 2018 and is anticipated to expand at a lucrative rate over the forecast period. Factors attributed to this high revenue are high prevalence of autoimmune disorders such as Polycystic Ovary Syndrome (PCOS) and cancer. Moreover, presence of advanced healthcare infrastructure, high disposable income, and novel therapeutic options are anticipated to further fuel the growth. Asia Pacific is anticipated to grow at the fastest rate over the forecast period owing to increasing awareness regarding available treatment options for alopecia and increasing per capital healthcare expenditure in emerging countries such as China and India.

Some of the key companies operating in the alopecia market are Cipla Inc.; Sun Pharmaceutical Industries Ltd.; Johnson and Johnson AG; Merck & Co, Inc.; and Lexington International LLC, Cirrus Hair Centers, Vita-Cos-Med Klett-Loch GmbH; Transitions Hair Pty Ltd, Follica, Inc. and Capillus.

Further key findings from the report suggest:

• Androgenetic alopecia segment led the market in 2018 with revenue of USD 7,242.7 million, owing to increasing prevalence of androgenetic alopecia and growing awareness regarding the availability of treatments.
• Homecare settings is expected to witness the fastest CAGR of 6% over the forecast period owing to increasing preference for convenience and ease of use along with increasing availability of OTC medication.
• Asia Pacific is expected to witness the fastest CAGR owing to the high population base, increasing availability of treatment options, and growing per capita healthcare expenditure.
• Some of the key players in the alopecia market are Cipla Inc.; Sun Pharmaceutical Industries Ltd.; Johnson and Johnson AG; Merck & Co, Inc.; and Lexington International LLC, Cirrus Hair Centers, Vita-Cos-Med Klett-Loch GmbH; Transitions Hair Pty Ltd, Follica, Inc. and Capillus.

Key Topics Covered

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.4 Information Analysis
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing

Chapter 2 Executive Summary
2.1 Alopecia Market Outlook, By Revenue (USD Million)
2.2 Alopecia Segment Outlook, By Revenue (USD Million)
2.3 Competititve Insights

Chapter 3 Alopecia Market Variables, Trends and Scope
3.1 Penetration & Growth Prospect Mapping
3.2 Product Pipeline Analysis, by Stage
3.3 Industry Value Chain Analysis
3.4 Market Dynamics
3.5 Alopecia Market Analysis Tools

Chapter 4 Alopecia Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization
4.3 Public Companies
4.4 Private Companies

Chapter 5 Alopecia Market: Disease Type Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Alopecia Market Share by Disease Type, 2018 & 2025
5.3 Segment Dashboard
5.4 Alopecia Areata
5.5 Androgenetic Alopecia
5.6 Others

Chapter 6 Alopecia Market: End Use Estimates & Trend Analysis
6.1 Definitions & Scope
6.2 Alopecia Market Share by End Use, 2018 & 2025
6.3 Segment Dashboard
6.4 Homecare Settings
6.5 Dermatology Clinics

Chapter 7 Alopecia Market: Sales Channel Estimates & Trend Analysis
7.1 Definitions & Scope
7.2 Alopecia Market Share by Sales channel, 2018 & 2025
7.3 Segment Dashboard
7.4 Prescriptions
7.5 OTC

Chapter 8 Alopecia Market: Gender Estimates & Trend Analysis
8.1 Definitions & Scope
8.2 Alopecia Market Share by Gender, 2018 & 2025
8.3 Segment Dashboard
8.4 Male
8.5 Female

Chapter 9 Alopecia Market: Regional Estimates & Trend Analysis, by Product
9.1 Regional Market Snapshot
9.2 Regional Market Share and Leading Players, 2018
9.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
9.4 Market Size, & Forecasts, and Trend Analysis, 2018 to 2025:

Chapter 10 Competitive Landscape
10.1 Company Profiles
10.1.1 Cipla Inc.
10.1.2 Sun Pharmaceuticals Industries Ltd.
10.1.3 Johnson & Johnson Services Inc.
10.1.4 Merck & Co. Inc.
10.1.5 Lexington International LLC
10.1.6 Cirrus Hair Centers
10.1.7 Vita-Cos-Med Klett-Loch GmbH
10.1.8 Transitions Hair Pty. Ltd.
10.1.9 Follica Inc.
10.1.10 Capillus
10.2 List of Other Manufacturers

For more information about this report visit https://www.researchandmarkets.com/r/92zb6e

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs